These parameters and protocols were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology. The American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma & Immunology have jointly accepted responsibility for establishing ‘‘Allergen immunotherapy.”
When selecting a dosing protocol you must first consider the environment the injection will be given. In the past we have seen allergen immunotherapy administered only within the clinical setting, in particular, an allergists office using a standard escalation to maintenance phase schedule. Today however, the escalation to maintenance phase is anything but standard due to a shift from requiring that the patient to adapt lifestyle to the therapy schedule to the therapy schedule being made adaptive for the patient’s lifestyle. Because of this, the protocols surrounding the build-up to maintenance phase therapy program are created to meet the individual need or environmental setting (i.e. injections at home).
Through leaders in the immunotherapy industry like Greer Laboratories and Holister-Steir who utilize the talents and work closely with the organizations noted above, Healthpoint uses the Immunotherapy Practice Parameters and Maintenance Dose Recommendations for environmental aeroallergens set forth by these organizations.